The P2Y12 receptor: no active metabolite, no party

Carlo Patrono

Risultato della ricerca: Contributo in rivistaArticolo in rivista

18 Citazioni (Scopus)

Abstract

Poor responders to clopidogrel have low levels of circulating active metabolite. However, in vitro experiments have shown that blood platelets from poor responders are fully inhibited by the active metabolite of this prodrug. Impaired platelet inhibition reflects inadequate plasma levels of active metabolites, and not differences in platelet P2Y12 receptor function.
Lingua originaleEnglish
pagine (da-a)271-272
Numero di pagine2
RivistaNATURE REVIEWS. CARDIOLOGY
Volume6
DOI
Stato di pubblicazionePubblicato - 2009

Keywords

  • Aryl Hydrocarbon Hydroxylases
  • Biological Availability
  • Biotransformation
  • Drug Interactions
  • Drug Resistance
  • Genetic Variation
  • Humans
  • Platelet Aggregation Inhibitors
  • Platelet Function Tests
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y12
  • Ticlopidine
  • Treatment Failure

Fingerprint

Entra nei temi di ricerca di 'The P2Y12 receptor: no active metabolite, no party'. Insieme formano una fingerprint unica.

Cita questo